伊丽莎白鼠
Lv1
60 积分
2023-12-07 加入
-
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
12天前
已完结
-
The never ending story of Hb-variants interferences on the measurement of HbA1c
1个月前
已完结
-
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
2个月前
已完结
-
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
2个月前
已完结
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2个月前
已完结
-
The Prevalence and Treatment of Diabetes in China From 2013 to 2018
2个月前
已完结
-
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
3个月前
已完结
-
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
4个月前
已完结
-
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli
4个月前
已完结
-
Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy
4个月前
已完结